22 July, 2024 | Monday | News

Everest Medicines Doses First Chinese Patient in Global Phase 2b Trial of Zetomipzomib for Lupus Nephritis

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today a...


22 July, 2024 | Monday | News

Agilent Technologies Launches ProteoAnalyzer System at SCGT Summit

Agilent Technologies Inc. announced the release of its new ProteoAnalyzer system, in addition to existing product updates at the Singapore Cell and Gene Therapy Pan Asia Summit (SCGT).  Agilent's new...


19 July, 2024 | Friday | News

Thermo Fisher Scientific and BioCell Innovations Sign MoU to Optimize Lentiviral-Based Immunotherapy Manufacturing in Asia-Pacific

  Thermo Fisher Scientific, a global leader in serving science, is excited to announce the signing of a Memorandum of Understanding (MoU) with BioCell Innovations Pte Ltd, a pioneer in lentivirus CAR cons...

Contract Services

23 July, 2024 | Tuesday | News

Agilent Acquires BIOVECTRA for $925 Million, Expanding Biopharma Capabilities

Agilent Technologies Inc. announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization, for $925 million. Based in Canada, BIOV...

Consumer Health

19 July, 2024 | Friday | News

Advances in HIV Treatment Bring Life Expectancy on Par with General Population, Gilead Sciences Study Highlights Key Blind Spots in Health Management

With the advancements in medical sciences, there is now very little difference between the life expectancy of people with HIV (PWH) and the general population. The increase in life expectancy has raised interes...

Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in